Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The Different Tactics of Foot-and-Mouth Disease Virus to Evade Innate Immunity.

Medina GN, Segundo FD, Stenfeldt C, Arzt J, de Los Santos T.

Front Microbiol. 2018 Nov 12;9:2644. doi: 10.3389/fmicb.2018.02644. eCollection 2018. Review.

2.

Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.

Visser LJ, Medina GN, Rabouw HH, de Groot RJ, Langereis MA, de Los Santos T, van Kuppeveld FJM.

J Virol. 2019 Jan 4;93(2). pii: e00922-18. doi: 10.1128/JVI.00922-18. Print 2019 Jan 15.

3.

The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P2-binding site that targets Gag to the cell periphery.

Watanabe SM, Medina GN, Eastep GN, Ghanam RH, Vlach J, Saad JS, Carter CA.

J Biol Chem. 2018 Dec 7;293(49):18841-18853. doi: 10.1074/jbc.RA118.003947. Epub 2018 Oct 11.

PMID:
30309982
4.

Interaction between FMDV Lpro and transcription factor ADNP is required for optimal viral replication.

Medina GN, Knudsen GM, Greninger AL, Kloc A, Díaz-San Segundo F, Rieder E, Grubman MJ, DeRisi JL, de Los Santos T.

Virology. 2017 May;505:12-22. doi: 10.1016/j.virol.2017.02.010. Epub 2017 Feb 17.

5.

Foot-and-mouth disease vaccines.

Diaz-San Segundo F, Medina GN, Stenfeldt C, Arzt J, de Los Santos T.

Vet Microbiol. 2017 Jul;206:102-112. doi: 10.1016/j.vetmic.2016.12.018. Epub 2016 Dec 19. Review.

PMID:
28040311
6.

Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.

Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T.

Virology. 2017 Feb;502:123-132. doi: 10.1016/j.virol.2016.12.021. Epub 2016 Dec 28.

7.

Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.

Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.

Clin Vaccine Immunol. 2015 Nov 25;23(2):125-36. doi: 10.1128/CVI.00426-15.

8.

Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.

Diaz-San Segundo F, Medina GN, Ramirez-Medina E, Velazquez-Salinas L, Koster M, Grubman MJ, de los Santos T.

J Virol. 2015 Nov 18;90(3):1298-310. doi: 10.1128/JVI.02167-15. Print 2016 Feb 1.

9.

Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly.

Ehrlich LS, Medina GN, Photiadis S, Whittredge PB, Watanabe S, Taraska JW, Carter CA.

Front Microbiol. 2014 May 20;5:234. doi: 10.3389/fmicb.2014.00234. eCollection 2014.

10.

ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade.

Ehrlich LS, Medina GN, Carter CA.

J Mol Biol. 2011 Oct 21;413(2):347-58. doi: 10.1016/j.jmb.2011.08.038. Epub 2011 Aug 22.

11.

Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release.

Ehrlich LS, Medina GN, Carter CA.

J Mol Biol. 2011 Jul 22;410(4):716-25. doi: 10.1016/j.jmb.2011.04.069.

12.

Sprouty 2 binds ESCRT-II factor Eap20 and facilitates HIV-1 gag release.

Medina GN, Ehrlich LS, Chen MH, Khan MB, Powell MD, Carter CA.

J Virol. 2011 Jul;85(14):7353-62. doi: 10.1128/JVI.00141-11. Epub 2011 May 4.

13.

Phosphoinositides direct equine infectious anemia virus gag trafficking and release.

Fernandes F, Chen K, Ehrlich LS, Jin J, Chen MH, Medina GN, Symons M, Montelaro R, Donaldson J, Tjandra N, Carter CA.

Traffic. 2011 Apr;12(4):438-51. doi: 10.1111/j.1600-0854.2010.01153.x. Epub 2011 Feb 1.

14.

Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV-1 Gag release.

Ehrlich LS, Medina GN, Khan MB, Powell MD, Mikoshiba K, Carter CA.

J Virol. 2010 Jul;84(13):6438-51. doi: 10.1128/JVI.01588-09. Epub 2010 Apr 28.

Supplemental Content

Loading ...
Support Center